Skip to content

Assessment effect of suppository of a drug based on Percian medicine on bacterial vaginosis

Assessment effect of suppository of a drug based on Percian medicine on bacterial vaginosis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016062528613N1
Enrollment
120
Registered
2016-10-22
Start date
2016-06-07
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bacterial vaginosis. Acute vaginitisinitis

Interventions

Intervention 1: Consumption of vaginal Suppository from medicinal products of iranian traditional medicine based on Tribulus terrestris. Intervention 2: Vaginal metronidazole suppository 500 mg fo
Treatment - Drugs
Consumption of vaginal Suppository from medicinal products of iranian traditional medicine based on Tribulus terrestris
Vaginal metronidazole suppository 500 mg for 7 nights

Sponsors

Tehran University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Outpatient women aged 18- 50 years with symptoms such as burning and itching refer and amsel criteria for bacterial vaginosis is positive for them; that Both treatments (chemical or herbal) do not use;They do not suffer from organic diseases such as cancer or other malignancies of the uterus or ovaries or Patients with chronic diseases. Exclusion criteria: Patients who use other antibiotics during the study; Patients who are experiencing possible side effect; Patients who have other medical interventions needed;This group of patients who have a severe form of the disease and other therapies and may require hospitalization have been included; Patients who request personal decision to withdraw from the study; Patients with immunosuppressive disorders; people with HIV; Patients with other infections such as genital herpes or trichomoniasis or fungal or gonorrhea at the same time with bacterial vaginosis; People who take other medication Such as the use of immunosuppressive drug or consumers of anti-inflammatory;consumers of showers vaginal and vaginal acidifying agents

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Amsel criteria. Timepoint: Before the intervention,10-14 days after begining of treatment. Method of measurement: Amsel have 4 criteria: key cells in the wet mount vaginal sample Vaginal dyscharge thin and white uniform - gray, white or yellowish, Vaginal pH equal to or greater than 4/5, positive whiff test. If at least 3 of the 4 cases mentioned above is positive, bacterial vaginosis is brought on .;Clinical signs for example Malodorous discharge, Itching, dyspareunia, having bad smell during sexual intercourse. Timepoint: Before the intervention, 10-14 day after intervention. Method of measurement: Measured by asking from patient.

Secondary

MeasureTime frame
Side effects. Timepoint: Within 10 to 14 days of intervention. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasrin Baery

Faculty of Traditional Medicine

n.baery76@yahoo.com baeerin891@mums.ac.ir+98 51 3855 2189

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026